Suzuken Co Ltd
TSE:9987
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
JP |
Suzuken Co Ltd
TSE:9987
|
361.5B JPY | 0.1 | ||
US |
Mckesson Corp
NYSE:MCK
|
70.5B USD | 0.2 | ||
US |
Cencora Inc
NYSE:COR
|
48.6B USD | 0.2 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
27.3B USD | 0.1 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD | 1 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | |
IT |
Amplifon SpA
MIL:AMP
|
7.6B EUR | 3.8 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
62.6B HKD | 0.1 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
53.8B CNY | 1.3 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
48.6B CNY | 0.2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.